|
5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- Suppliers list
|
|
| | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- Basic information |
| Product Name: | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- | | Synonyms: | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- | | CAS: | 2483831-19-0 | | MF: | C22H34O2 | | MW: | 330.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2483831-19-0.mol |  |
| | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- Chemical Properties |
| solubility | Ethanol: 1 mg/ml |
| | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- Usage And Synthesis |
| Description | Eicosapentaenoic acid-d5 ethyl ester is intended for use as an internal standard for the quantification of eicosapentaenoic acid ethyl ester by GC- or LC-MS. Eicosapentaenoic acid (EPA) ethyl ester is an esterified form of the ω-3 fatty acid EPA . Dietary administration of EPA ethyl ester (41.4 g/100 g of total dietary fatty acids) increases the ex vivo activity of hepatic β-oxidation enzymes.1,2 It also reduces total hepatic triglyceride levels and increases the ω-3 fatty acid content of hepatic triglycerides and phospholipids, as well as increases the total levels of ω-3 fatty acids in rats. EPA ethyl ester (1 g/kg) reverses increases in plasma cholesterol levels and reduces circulating triglyceride levels in rats fed a high-fat diet.3 Formulations containing eicosapentaenoic acid ethyl ester have been used as adjuncts in the treatment of hypertriglyceridemia. | | Uses | Eicosapentaenoic acid ethyl ester-d5-1 (EPA ethyl ester-d5) is deuterium labeled Eicosapentaenoic acid ethyl ester[1]. | | References | 1. Hong, D.D., Takahashi, Y., Kushiro, M., et al. Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat Biochim. Biophys. Acta 1635(1),29-36(2003).
2. Arachchige, P.G., Takahashi, Y., and Ide, T. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats Metabolism 55(3),381-390(2006).
3. Pérez-Echarri, N., Pérez-Matute, P., Marcos-Gómez, B., et al. Down-regulation in muscle and liver lipogenic genes: EPA ethyl ester treatment in lean and overweight (high-fat-fed) rats J. Nutr. Biochem. 20(9),705-714(2008). |
| | 5,8,11,14,17-Eicosapentaenoic-19,19,20,20,20-d5 acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- Preparation Products And Raw materials |
|